ObsEva Announces Appointment of Luigi Marro as Chief Transformation Officer Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange   GENEVA, Switzerland – September 30, 2021 – ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company developing and...

Axtria Honored on NJBIZ’s “Top 250 Privately Held Companies” For The Fourth Time Berkeley Heights, NJ, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Axtria, a global leader in software technology and data analytics for the life sciences industry, is delighted to announce its ranking...

Marina Biotech Appoints Jay D. Schwartz to serve as Senior Vice President, Commercial Operations City of Industry, CA, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of...